Related references
Note: Only part of the references are listed.Efficacy of a Tetravalent Chimeric Dengue Vaccine (DENVax) in Cynomolgus Macaques
Jorge E. Osorio et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2011)
Dengue-How Best to Classify It
Anon Srikiatkhachorn et al.
CLINICAL INFECTIOUS DISEASES (2011)
SPICE: Exploration and Analysis of Post-Cytometric Complex Multivariate Datasets
Mario Roederer et al.
CYTOMETRY PART A (2011)
Memory CD8(+) T cells from naturally acquired primary dengue virus infection are highly cross-reactive
Heather Friberg et al.
IMMUNOLOGY AND CELL BIOLOGY (2011)
Intracellular Cytokine Production by Dengue Virus-specific T cells Correlates with Subclinical Secondary Infection
Steven Hatch et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
A human challenge model for dengue infection reveals a possible protective role for sustained interferon gamma levels during the acute phase of illness
V. J. Gunther et al.
VACCINE (2011)
Cross-Reactivity and Expansion of Dengue-Specific T cells During Acute Primary and Secondary Infections in Humans
Heather Friberg et al.
SCIENTIFIC REPORTS (2011)
Immunity to dengue virus: a tale of original antigenic sin and tropical cytokine storms
Alan L. Rothman
NATURE REVIEWS IMMUNOLOGY (2011)
IL-10 production differentially influences the magnitude, quality, and protective capacity of Th1 responses depending on the vaccine platform
Patricia A. Darrah et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
Phenotypic and Functional Profile of HIV-Inhibitory CD8 T Cells Elicited by Natural Infection and Heterologous Prime/Boost Vaccination
Stephanie A. Freel et al.
JOURNAL OF VIROLOGY (2010)
Dengue: a continuing global threat
Maria G. Guzman et al.
NATURE REVIEWS MICROBIOLOGY (2010)
Immunodominant T-cell responses to dengue virus NS3 are associated with DHF
Thaneeya Duangchinda et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Differential In Vivo Clearance and Response to Secondary Heterologous Infections by H2(b)-Restricted Dengue Virus-Specific CD8(+) T Cells
Coreen M. Beaumier et al.
VIRAL IMMUNOLOGY (2010)
Serotype-Specific Differences in the Risk of Dengue Hemorrhagic Fever: An Analysis of Data Collected in Bangkok, Thailand from 1994 to 2006
Jessica R. Fried et al.
PLOS NEGLECTED TROPICAL DISEASES (2010)
A Protective Role for Dengue Virus-Specific CD8+ T Cells
Lauren E. Yauch et al.
JOURNAL OF IMMUNOLOGY (2009)
Tuberculosis Subunit Vaccination Provides Long-Term Protective Immunity Characterized by Multifunctional CD4 Memory T Cells
Thomas Lindenstrom et al.
JOURNAL OF IMMUNOLOGY (2009)
Understanding the contribution of cellular immunity to dengue disease pathogenesis
Anuja Mathew et al.
IMMUNOLOGICAL REVIEWS (2008)
Dengue and hemorrhagic fever - A potential threat to public health in the United States
David M. Morens et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)
Multifunctional, high-level cytokine-producing Th1 cells in the lung, but not spleen, correlate with protection against Mycobacterium tuberculosis aerosol challenge in mice
Emily K. Forbes et al.
JOURNAL OF IMMUNOLOGY (2008)
T-cell quality in memory and protection: implications for vaccine design
Robert A. Seder et al.
NATURE REVIEWS IMMUNOLOGY (2008)
Immunisation with BCG and recombinant MVA85A induces long-lasting, polyfunctional Mycobacterium tuberculosis-specific CD4+ memory T lymphocyte populations
Natalie E. R. Beveridge et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2007)
Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major
Patricia A. Darrah et al.
NATURE MEDICINE (2007)
Immunization with vaccinia virus induces polyfunctional and phenotypically distinctive CD8+ T cell responses
Melissa L. Precopio et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
The live attenuated dengue serotype 1 vaccine rDEN1Δ30 is safe and highly immunogenic in healthy adult volunteers
Anna P. Durbin et al.
HUMAN VACCINES (2006)
HIV-1-specific IFN-γ/IL-2-secreting CD8 T cells support CD4-independent proliferation of HIV-1-specific CD8 T cells
SC Zimmerli et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
rDEN4Δ30, a live attenuated dengue virus type 4 vaccine candidate, is safe, immunogenic, and highly infectious in healthy adult volunteers
AP Durbin et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
Selection for virulent dengue viruses occurs in humans and mosquitoes
R Cologna et al.
JOURNAL OF VIROLOGY (2005)
The multifaceted relationship between IL-10 and adaptive immunity: putting together the pieces of a puzzle
S Mocellin et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2004)
Skewed representation of functionally distinct populations of virus-specific CD4 T cells in HIV-1-infected subjects with progressive disease: changes after antiretroviral therapy
A Harari et al.
BLOOD (2004)
Quantitation of dengue virus specific CD4+T cells by intracellular cytokine staining
MM Mangada et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2004)
HIV-1 viremia prevents the establishment of interleukin 2-producing HIV-specific memory CD4+ T cells endowed with proliferative capacity
SA Younes et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Original antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever
J Mongkolsapaya et al.
NATURE MEDICINE (2003)
Presence of HIV-1 gag-specific IFN-γ+IL-2+ and CD28+IL-2+ CD4 T cell responses is associated with nonprogression in HIV-1 infection
MJ Boaz et al.
JOURNAL OF IMMUNOLOGY (2002)
Differing influences of virus burden and immune activation on disease severity in secondary dengue-3 virus infections
DH Libraty et al.
JOURNAL OF INFECTIOUS DISEASES (2002)
Epidemiologic studies on dengue in Santiago de Cuba, 1997
MG Guzmán et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2000)
Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity
DW Vaughn et al.
JOURNAL OF INFECTIOUS DISEASES (2000)
Share Paper
